Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

ClinicalTrials.gov ID: NCT00071448

Public ClinicalTrials.gov record NCT00071448. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 7:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients.

Study identification

NCT ID
NCT00071448
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
378 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 18 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2002
Primary completion
May 31, 2004
Completion
May 31, 2004
Last update posted
Dec 21, 2016

2002 – 2004

United States locations

U.S. sites
76
U.S. states
32
U.S. cities
67
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35294
Novo Nordisk Investigational Site Mobile Alabama 36617
Novo Nordisk Investigational Site Phoenix Arizona 85013
Novo Nordisk Investigational Site Tucson Arizona 85712
Novo Nordisk Investigational Site Loma Linda California 92354
Novo Nordisk Investigational Site Long Beach California 90806
Novo Nordisk Investigational Site Los Angeles California 90027
Novo Nordisk Investigational Site Sacramento California 95817
Novo Nordisk Investigational Site San Diego California 92093
Novo Nordisk Investigational Site San Diego California 92123
Novo Nordisk Investigational Site Englewood Colorado 80110
Novo Nordisk Investigational Site Hartford Connecticut 06106
Novo Nordisk Investigational Site New Haven Connecticut 06520
Novo Nordisk Investigational Site Gainesville Florida 32605
Novo Nordisk Investigational Site Gainesville Florida 32608
Novo Nordisk Investigational Site Miami Florida 33136
Novo Nordisk Investigational Site Orlando Florida 32806-1101
Novo Nordisk Investigational Site Pensacola Florida 32504
Novo Nordisk Investigational Site Tallahassee Florida 32308
Novo Nordisk Investigational Site Tampa Florida 33612
Novo Nordisk Investigational Site Atlanta Georgia 30342
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Indianapolis Indiana 46202-2879
Novo Nordisk Investigational Site Indianapolis Indiana 46250
Novo Nordisk Investigational Site Iowa City Iowa 52242
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808
Novo Nordisk Investigational Site New Orleans Louisiana 70127-5430
Novo Nordisk Investigational Site Baltimore Maryland 21201
Novo Nordisk Investigational Site Baltimore Maryland 21229
Novo Nordisk Investigational Site Boston Massachusetts 02115
Novo Nordisk Investigational Site Boston Massachusetts 02215
Novo Nordisk Investigational Site Worcester Massachusetts 01655
Novo Nordisk Investigational Site Ann Arbor Michigan 48109
Novo Nordisk Investigational Site Minneapolis Minnesota 55416
Novo Nordisk Investigational Site Rochester Minnesota 55905
Novo Nordisk Investigational Site Kansas City Missouri 64108
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Omaha Nebraska 68198-3020
Novo Nordisk Investigational Site Hackensack New Jersey 07601
Novo Nordisk Investigational Site Morristown New Jersey 07962
Novo Nordisk Investigational Site Paterson New Jersey 07503
Novo Nordisk Investigational Site Albuquerque New Mexico 87102
Novo Nordisk Investigational Site Albany New York 12208
Novo Nordisk Investigational Site Brooklyn New York 11219
Novo Nordisk Investigational Site Buffalo New York 53226
Novo Nordisk Investigational Site Mineola New York 11501
Novo Nordisk Investigational Site New York New York 10022
Novo Nordisk Investigational Site New York New York 10029
Novo Nordisk Investigational Site Rochester New York 14642
Novo Nordisk Investigational Site Chapel Hill North Carolina 27599-7220
Novo Nordisk Investigational Site Akron Ohio 44308-1062
Novo Nordisk Investigational Site Cleveland Ohio 44195
Novo Nordisk Investigational Site Columbus Ohio 43231
Novo Nordisk Investigational Site Dayton Ohio 45404
Novo Nordisk Investigational Site Portland Oregon 97227
Novo Nordisk Investigational Site Danville Pennsylvania 17822
Novo Nordisk Investigational Site Erie Pennsylvania 16507
Novo Nordisk Investigational Site Hershey Pennsylvania 17033
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15213-3417
Novo Nordisk Investigational Site Charleston South Carolina 29425
Novo Nordisk Investigational Site Columbia South Carolina 29203
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Memphis Tennessee 38103
Novo Nordisk Investigational Site Memphis Tennessee 38119
Novo Nordisk Investigational Site Corpus Christi Texas 78411
Novo Nordisk Investigational Site Dallas Texas 75235
Novo Nordisk Investigational Site Lackland City Texas 78236
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site San Antonio Texas 78284
Novo Nordisk Investigational Site Temple Texas 76508
Novo Nordisk Investigational Site Salt Lake City Utah 84132
Novo Nordisk Investigational Site Norfolk Virginia 23510
Novo Nordisk Investigational Site Spokane Washington 99201
Novo Nordisk Investigational Site Morgantown West Virginia 26506
Novo Nordisk Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00071448, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2016 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00071448 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →